Annoroad Genomics
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A premier genomics service and solution provider enabling precision medicine and large-scale genetic research in China.
Genetics & GenomicsDiagnostics
Technology Platform
An integrated platform combining high-capacity next-generation sequencing with proprietary bioinformatics pipelines and AI-driven data analysis for genomic interpretation.
Opportunities
Massive growth potential from the integration of genomic testing into routine clinical care and national public health programs in China.
Risk Factors
Regulatory uncertainty and potential pricing pressure in the clinical testing market, alongside rapid technological obsolescence.
Competitive Landscape
A key competitor to BGI in the large and fragmented Chinese clinical genomics and sequencing services market.